The Jackson Laboratory
- Academic, tech transfer
- Biotech – industrial & Environmental
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Diagnostics
- Digital health
- Institute, hospital research
- Investor (buy-side or sell-side research)
- Public, NPO, govt., economic development
- Medical device or technology
The Jackson Laboratory is a global leader in mammalian genetics and human genomics, committed to advancing scientific discovery and its translation to benefit patients. We offer a robust portfolio of faculty-led innovations available for out-licensing and partnership, spanning neurodegeneration, regenerative medicine, cardiovascular and rare diseases, and infectious disease. Our Rare Disease Translational Center (RDTC) accelerates progress from gene discovery to therapy development through integrated, collaborative partnerships with academia, biotech, and patient foundations. Atlas™, our next-generation in vivo antibody discovery platform, delivers high-quality, fully human monoclonal and bispecific antibodies—accelerating timelines and enhancing candidate potential within existing workflows.



